Getting Ozempic for weight loss starts with a prescription from a healthcare provider, but there’s an important catch: Ozempic is FDA-approved only for type 2 diabetes, not weight loss. Any prescription for weight loss is considered “off-label,” meaning your provider is using clinical judgment to prescribe it for a purpose beyond its official approval. This distinction affects everything from whether you qualify to whether your insurance will cover it.
Why Ozempic for Weight Loss Is Off-Label
Ozempic and Wegovy contain the same active ingredient, semaglutide, made by the same manufacturer. The difference is their approved uses. Wegovy is the version FDA-approved specifically for weight management in adults and children 12 and older. Ozempic is approved for managing type 2 diabetes and reducing cardiovascular and kidney risks in people with diabetes.
Weight loss is a well-documented side effect of Ozempic, which is why many providers prescribe it off-label for that purpose. But Wegovy comes in a higher maximum dose (2.4 mg per week versus Ozempic’s 2 mg), making it the more targeted option for weight loss. If your provider prescribes Ozempic instead of Wegovy, it’s often because of availability, cost differences, or insurance coverage specifics.
Who Qualifies
Whether your provider prescribes Ozempic off-label or steers you toward Wegovy, the eligibility criteria for semaglutide-based weight loss treatment generally follow the same thresholds. You typically need a BMI of 30 or higher, or a BMI of 27 or higher combined with at least one weight-related condition like high blood pressure, type 2 diabetes, or high cholesterol.
BMI isn’t a perfect measure, and some providers take a more individualized approach, considering your overall health, weight history, and previous attempts at lifestyle changes. But insurance companies almost universally use these BMI cutoffs when deciding whether to cover the prescription, so they remain the practical standard.
Steps to Get a Prescription
You have several options for getting evaluated. Your primary care doctor is the most straightforward starting point. Many providers are comfortable prescribing semaglutide for weight management, especially if you have a documented history of weight-related health issues. Endocrinologists and obesity medicine specialists are other options, particularly if your primary care provider is hesitant to prescribe off-label.
Telehealth weight loss clinics have also become a common path. Several online platforms now connect patients with providers who evaluate and prescribe GLP-1 medications remotely, often with faster turnaround than a traditional office visit. Be cautious with any service that guarantees a prescription before evaluating you, as a legitimate provider will review your medical history, current medications, and health conditions before deciding if semaglutide is appropriate.
During your visit, expect questions about your weight history, diet and exercise habits, any previous weight loss medications you’ve tried, and your family medical history. Your provider will likely order basic bloodwork and check your blood pressure. If you have type 2 diabetes, getting an Ozempic prescription is more straightforward since that’s its approved use and weight loss becomes a welcome additional benefit.
Who Should Not Take It
Ozempic carries an FDA boxed warning (the most serious type) about thyroid tumors. In animal studies, semaglutide caused thyroid C-cell tumors at doses similar to those used in humans. Whether this risk translates to people isn’t yet known, but as a precaution, Ozempic is contraindicated if you or a close family member has a history of medullary thyroid carcinoma or a condition called Multiple Endocrine Neoplasia syndrome type 2. You also cannot take it if you’ve had a serious allergic reaction to semaglutide in the past.
Your provider will also evaluate whether you have a history of pancreatitis, gallbladder disease, or severe kidney problems, all of which require careful consideration before starting treatment.
What the First Months Look Like
Ozempic is a once-weekly injection you give yourself with a pre-filled pen, typically in the stomach, thigh, or upper arm. You pick a day of the week and stick with it, though you can shift the day as long as there are at least two days between doses.
The starting dose is 0.25 mg per week, which is intentionally too low to be therapeutic. This first month is purely about letting your body adjust and minimizing side effects, particularly nausea. From there, your provider will gradually increase the dose over several months. The maximum recommended dose is 2 mg per week, but many people find effective weight loss at lower doses. This slow escalation is why you shouldn’t expect dramatic results in the first few weeks.
If you miss a dose, take it within five days. If more than five days have passed, skip it and resume on your next scheduled day.
Cost Without Insurance
Ozempic’s list price is about $1,028 per pen, which is a one-month supply. Most people don’t pay this full amount, but without insurance or discounts, it’s an expensive medication.
Novo Nordisk, the manufacturer, offers a savings program with several tiers. If you have commercial insurance that covers Ozempic, you can pay as little as $25 per month, with a maximum savings of $100 per month for up to 48 months. If you’re uninsured or paying out of pocket, the program offers a flat rate of $349 per month for the 0.25 mg, 0.5 mg, or 1 mg doses, and $499 per month for the 2 mg dose. New patients filling through the NovoCare Pharmacy can pay $199 per month for the lower starting doses through June 30, 2026.
One major exclusion: if you have any government insurance (Medicare, Medicaid, Tricare, or even a commercial plan combined with a government plan), you’re not eligible for the manufacturer savings program.
Insurance Coverage Challenges
This is where the off-label distinction matters most. Many insurance plans cover Ozempic for type 2 diabetes but deny coverage when it’s prescribed purely for weight loss. Some plans cover Wegovy for weight loss but not Ozempic, and others cover neither. Your provider’s office can submit a prior authorization request, which is essentially a formal argument to your insurer that the medication is medically necessary for you.
If your insurer denies Ozempic for weight loss, you have a few options. Ask your provider about appealing the decision with supporting documentation of your weight-related health conditions. Check whether your plan covers Wegovy instead, since it has the explicit weight loss approval that insurers look for. Or explore the manufacturer’s savings programs and independent pharmacy discount cards, which can sometimes bring the price below what you’d pay through insurance anyway.
Supply Availability
Ozempic was in shortage from 2022 through early 2025 due to surging demand. As of February 2025, the FDA confirmed the shortage is resolved, with the manufacturer’s production capacity now meeting national demand. Semaglutide no longer appears on the FDA’s drug shortage list, so filling a prescription should no longer involve the pharmacy-hopping and waitlists that were common during the shortage years.